MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Total Assets 2011-2026 | BRKR
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.81 B | 4.25 B | 3.61 B | 3.65 B | 3.05 B | 2.77 B | 2.13 B | 1.95 B | 1.81 B | 1.73 B | 1.86 B | 1.99 B | 1.86 B | 1.71 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.81 B | 1.71 B | 2.73 B |
Quarterly Total Assets Bruker Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.43 B | 5.93 B | 5.81 B | 6.11 B | 5.9 B | - | 4.25 B | 3.82 B | 3.86 B | 3.76 B | 3.61 B | 3.34 B | - | 3.55 B | 3.65 B | 3.13 B | 3.09 B | 3.03 B | 3.05 B | 3.05 B | 3.05 B | 3.05 B | 2.77 B | 2.77 B | 2.77 B | 2.77 B | 2.13 B | 2.13 B | 2.13 B | 2.13 B | 1.95 B | 1.95 B | 1.95 B | 1.95 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | 1.73 B | 1.73 B | 1.73 B | 1.73 B | 1.86 B | 1.86 B | 1.86 B | 1.86 B | 1.99 B | 1.99 B | 1.99 B | 1.99 B | 1.86 B | 1.86 B | 1.86 B | 1.86 B | 1.71 B | 1.71 B | 1.71 B | 1.71 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.43 B | 1.71 B | 2.73 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
6.21 B | $ 174.53 | -1.3 % | $ 13.1 B |  USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 11.07 | -5.06 % | $ 1.66 B | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 277.5 | -1.3 % | $ 7.83 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.22 | 0.33 % | $ 1.65 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.36 | -0.3 % | $ 126 M |  France |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.6 | -2.45 % | $ 37.3 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 61.28 | -2.05 % | $ 90.7 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 8.96 | -2.29 % | $ 254 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 24.41 | 0.04 % | $ 206 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
5.3 B | $ 91.4 | -0.61 % | $ 12.4 B | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.15 | 0.24 % | $ 878 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.88 | 0.3 % | $ 354 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Inogen
INGN
|
299 M | $ 6.66 | -0.15 % | $ 177 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 56.69 | 6.2 % | $ 1.66 B | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.93 | 0.93 % | $ 1.15 B | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.04 | 0.97 % | $ 17.6 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 86.67 | -0.93 % | $ 3.01 B | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.61 | -0.05 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 79.15 | -3.13 % | $ 46.3 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.94 | -0.44 % | $ 374 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.89 | 0.53 % | $ 1.15 M | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 63.37 | -2.0 % | $ 3.46 B |  Britain |
 |
LENSAR
LNSR
|
71.4 M | $ 5.46 | -1.27 % | $ 65.3 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |